Phase II trial of tesetaxel, an oral taxane, as second-line therapy for patients with advanced gastroesophageal cancer.
Mary Frances Mulcahy
No relevant relationships to disclose
Jackie S. Baker
Research Funding - Genta
Weijing Sun
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose
Hassan Danesi
Employment or Leadership Position - Genta
Loretta Itri
Employment or Leadership Position - Genta; Genta (I)
Stock Ownership - Genta (B)
Jaffer A. Ajani
Research Funding - Genta